Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 mars 2025 11h02 HE | Source: Research and Markets

Allogeneic CAR-T Cell Patent Landscape and Forecast Report 2024-2032, Profiles of Artiva Biotherapeutics, Poseida Therapeutics, Nanjing Beiheng Biological Technology, NantCell, GC Cell, BMS, Compugen

Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Allogeneic CAR-T Cell Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global allogenic...
05 févr. 2025 07h45 HE | Source: Research and Markets

CAR T-Cell Therapy Market Forecasts to 2035, with Competitor Profiles of Autolus, Bluebird Bio, Carsgen Therapeutics, Cellectis, Noile-Immune Biotech, Shanghai GeneChem, Takara Bio and More

Dublin, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035" report has been added to ResearchAndMarkets.com's offering. The global CAR...
03 janv. 2025 04h09 HE | Source: Research and Markets

CAR-T Cell Therapy Market Research 2024-2025: Navigating the CAR-T Landscape, Major Players, Recent Approvals, and Pioneering Therapies

Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapy Market - Market Size, Forecasts, Trials, and Trends, 2025" report has been added to ResearchAndMarkets.com's offering. This...
02 déc. 2024 06h31 HE | Source: Research and Markets

CAR T-cell Therapy Strategic Business Research Report 2024: Global Market to Reach $10.8 Billion by 2030 - Expanding Clinical Applications Beyond Blood Cancers Expands Opportunities

Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for CAR T-cell...
23 oct. 2024 12h03 HE | Source: Research and Markets

Spain CAR-T Cell Therapy Market Forecast to 2029, Featuring Strategic Profiles of Gilead Sciences, Novartis Int'l, Bristol Myers Squibb, AbbVie, AMGEN, Pfizer, Merck & Co, Johnson & Johnson

Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Spain CAR-T Cell Therapy Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
16 oct. 2024 04h02 HE | Source: Research and Markets

CAR-T Cell Therapy Market Research 2024: Regulatory Approvals, Pricing, Reimbursement, Degree of Market Penetration, Mergers and Acquisitions, IPOs, and Financing Events

Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials, and Trends, 2024" report has been added to ResearchAndMarkets.com's offering. ...
24 juin 2024 10h00 HE | Source: Research and Markets

Global CAR-T Cell Therapy Market Report 2024: Detailed Coverage of the Approved CAR-T Products, including Regulatory Approvals, Pricing, Reimbursement and Degree of Market Penetration

Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials, and Trends, 2024" report has been added to ResearchAndMarkets.com's offering. ...
05 juin 2024 08h03 HE | Source: Research and Markets

CAR T Cell Therapy Market Industry Trends and Global Forecasts to 2035: Rising Leukemia and Lymphoma Cases Boost CAR T Cell Therapy Market, with Positive Phase III Trials Expanding Treatment Potential

Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "CAR T Cell Therapy Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Indication, Target Antigens, Key Geographical...
27 mai 2024 09h43 HE | Source: Research and Markets

Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market to Surge to US$ 11.28 Billion by 2034, Propelled by Tranformative Cancer Treatments

Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report...
15 avr. 2024 07h20 HE | Source: Research and Markets

Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim

Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Liver Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides...

Page suivante keyboard_arrow_right